In the Boardroom
Refine Search
Pharmaceutical
Starboard Value, a privately owned hedge fund sponsor, has written a strongly-worded letter to US specialty drugmaker Depomed, in which the investor now owns almost 10% of the shares. 11 April 2016
Pharmaceutical
Japanese pharma major Daiichi Sankyo this week announced its five-year business plan for the fiscal period 2016-2020. 1 April 2016
Biotechnology
US biotech major Biogen has recruited former Merck & Co executive Michel Vounatsos as the company’s executive vice president and chief commercial officer, effective April 18, 2016. 30 March 2016
Pharmaceutical
French pharma giant Sanofi has announced the appointment of leading immunology researcher Yong-Jun Liu as its head of research. 29 March 2016
Biotechnology
The chief executive of GenSpera, a US biotech company, has resigned. 23 March 2016
Biotechnology
Valneva has now established a commercial operation in the UK. 23 March 2016
Pharmaceutical
Japanese drugmaker Sosei Group has announced that Peter Bains will take over as both chief operating officer and chief executive in the next three months. 22 March 2016
Pharmaceutical
Valeant Pharmaceuticals International today announced that it has initiated a search for a new chief executive officer, and appointed William Ackman, chief executive of hedge fund Pershing Square Management, to its board of directors. 21 March 2016
Pharmaceutical
US clinical-stage cancer drug develop Threshold Pharmaceuticals has announced the appointment of Stewart Kroll as chief operating officer. 21 March 2016
Pharmaceutical
The chief executive of UK pharma major GlaxoSmithKline, Sir Andrew Witty, will retire in March next year, the company announced on Thursday. 17 March 2016
Pharmaceutical
French drugmaker Sanofi has appointed Ameet Nathwani as its new chief medical officer, it has been announced. 10 March 2016
Biotechnology
US clinical-stage biotechnology company Rigel Pharmaceuticals has appointed Anne-Marie Duliege as its new chief medical officer, it has been announced. 9 March 2016
Biotechnology
Virginia Jamieson is returning as the chief medical officer of Swiss biotechnology firm Kuros Biosciences, it was announced on Tuesday. 8 March 2016
Pharmaceutical
Canadian drugmaker Valeant Pharmaceuticals has confirmed that executive vice president, company group chairman, Deb Jorn, has resigned from the company with immediate effect. 4 March 2016
Pharmaceutical
Japanese drug major Astellas Pharma has appointed Yukio Matsui as president of EMEA operations, with responsibility for the company’s commercial operations in Europe, the Middle East and Africa, it has been announced. 4 March 2016
Pharmaceutical
Switzerland-based privately-held drugmaker Ferring Pharmaceuticals has appointed Aaron Graff as chief executive of Ferring Holding Inc. 2 March 2016
Generics
Valeant Pharmaceuticals has announced the return of Michael Pearson as chief executive following his recovery from severe pneumonia. 29 February 2016
Pharmaceutical
Swedish Orphan Biovitrum has released financial results, showing that total net revenue for the fourth quarter of 2015 has increased 15% (+9% at constant currencies) to 814 million kronor ($96.2 million). 26 February 2016
Pharmaceutical
German pharma major Bayer has announced that Werner Baumann is to take over as chairman on May 1. 25 February 2016
Pharmaceutical
UK-based life sciences firm Abzena says that its US biomanufacturing subsidiary PacificGMP has made two senior appointments to support its growth. 23 February 2016
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze